Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   IRANIAN JOURNAL OF PEDIATRICS   AUGUST 2014 , Volume 24 , Number 4; Page(s) 371 To 380.
 
Paper: 

THE EXPRESSION AND PROGNOSTIC IMPACT OF CD95 DEATH RECEPTOR AND CD20, CD34 AND CD44 DIFFERENTIATION MARKERS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

 
 
Author(s):  KAMAZANI FATEMEH M., BAHOUSH MEHDIABADI GHOLAMREZA, AGHAEIPOUR MAHNAZ, VAELI SHAHRAM, AMIRGHOFRAN ZAHRA*
 
* DEPARTMENT OF IMMUNOLOGY, MEDICAL SCHOOL, SHIRAZ UNIVERSITY OF MEDICAL SCIENCES, 71345-1798, SHIRAZ, IRAN
 
Abstract: 

Objective: This study investigated the expression and prognostic significance of the CD95 death receptor and CD20, a B cell-lineage associated marker, along with CD34 and CD44 non-lineage associated molecules in Iranian children with acute lymphoblastic leukemia (ALL).
Methods: We performed immunophenotyping for expressions of the molecules in blood samples from children diagnosed with ALL by using a panel of monoclonal antibodies for flow cytometry analysis. The expression of markers was evaluated in relation to clinical and paraclinical features as well as response to treatment in the patients.
Findings: CD95 showed a higher expression in T-ALL compared to B-ALL (P<0.001). Analysis of the clinical and laboratory findings at diagnosis in the group of B-ALL patients revealed an association between CD95 expression with lower white blood cell (WBC) numbers and bone marrow blasts (P<0.05). We detected a positive correlation between the expressions of CD95 and CD44 (r=0.445, P<0.01) in B-ALL patients. There was an association between CD20 expression and several poor prognostic factors that included increased extramedullary involvement (EMI) and decreased platelet numbers (P<0.008). The mean expression of CD34 in B-ALL was higher than T-ALL (P=0.004). At follow-up, complete remission duration (CRD) and survival duration did not significantly differ between patients who were positive or negative for each marker.
Conclusion: Association of the studied molecules with several prognostic factors implies the significance of CD95 molecule as favorable and CD20 as unfavorable prognostic markers for childhood ALL.

 
Keyword(s): ACUTE LYMPHOBLASTIC LEUKEMIA, CD95, CD20, CD34, PROGNOSIS
 
 
References: 
  • Not Registered.
  •  
 
+ Click to Cite.
APA: Copy

KAMAZANI, F., & BAHOUSH MEHDIABADI, G., & AGHAEIPOUR, M., & VAELI, S., & AMIRGHOFRAN, Z. (2014). THE EXPRESSION AND PROGNOSTIC IMPACT OF CD95 DEATH RECEPTOR AND CD20, CD34 AND CD44 DIFFERENTIATION MARKERS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA. IRANIAN JOURNAL OF PEDIATRICS, 24(4), 371-380. https://www.sid.ir/en/journal/ViewPaper.aspx?id=408023



Vancouver: Copy

KAMAZANI FATEMEH M., BAHOUSH MEHDIABADI GHOLAMREZA, AGHAEIPOUR MAHNAZ, VAELI SHAHRAM, AMIRGHOFRAN ZAHRA. THE EXPRESSION AND PROGNOSTIC IMPACT OF CD95 DEATH RECEPTOR AND CD20, CD34 AND CD44 DIFFERENTIATION MARKERS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA. IRANIAN JOURNAL OF PEDIATRICS. 2014 [cited 2021May16];24(4):371-380. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=408023



IEEE: Copy

KAMAZANI, F., BAHOUSH MEHDIABADI, G., AGHAEIPOUR, M., VAELI, S., AMIRGHOFRAN, Z., 2014. THE EXPRESSION AND PROGNOSTIC IMPACT OF CD95 DEATH RECEPTOR AND CD20, CD34 AND CD44 DIFFERENTIATION MARKERS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA. IRANIAN JOURNAL OF PEDIATRICS, [online] 24(4), pp.371-380. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=408023.



 
  pdf-File
Yearly Visit 48
 
Latest on Blog
Enter SID Blog